Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study

Detalles Bibliográficos
Autores principales: Chang, Anne Lynn S., Tran, Duy C., Cannon, John G. D., Li, Shufeng, Jeng, Mark, Patel, Roma, Van der Bokke, Lindsay, Pague, Alana, Brotherton, Richard, Rieger, Kerri E., Satpathy, Ansuman T., Yost, Kathryn E., Reddy, Sunil, Sarin, Kavita, Colevas, A. Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839543/
https://www.ncbi.nlm.nih.gov/pubmed/30145186
http://dx.doi.org/10.1016/j.jaad.2018.08.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839543/
https://www.ncbi.nlm.nih.gov/pubmed/30145186
http://dx.doi.org/10.1016/j.jaad.2018.08.017

Ejemplares similares